SBIR PHASE I TOPIC 406: DEVELOPING AVIDENT HEALTH'S MYNAVIGATOR MHEALTH APPLICATION FOR USE IN PATIENT NAVIGATOR BREAST CANCER CARE WORKFLOWS

SBIR 第一阶段主题 406：开发 Avident Health 的 MYNAVIGATOR MHEALTH 应用程序以用于患者导航乳腺癌护理工作流程

• 批准号: 10267368
• 负责人: TAN LU
• 金额: $ 36.13万
• 依托单位: AVIDENT HEALTH, LLC
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-16 至 2021-06-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10267368
• 关键词: Anxiety; Back; Breast Cancer Patient; Collaborations; Communication; Data; Development; Electronic Health Record; Evaluation; Family Caregiver; Feedback; Focus Groups; Health; Health care facility; Human; Intellectual Property; Knowledge; Legal patent; Methods; Mobile Health Application; Patient Care Team; Patients; Phase; Research Design; Research Institute; Research Methodology; Review Literature; Small Business Innovation Research Grant; Surveys; Testing; cancer care; design; effectiveness testing; heuristics; improved; malignant breast neoplasm; patient engagement; product development; prototype; software development; technological innovation; tool; usability

Avident Health, in partnership with MedStar Health Research Institute (MHRI), will develop the MyNavigator mHealth App and conduct a usability study for breast cancer Patient Navigators (PNs) and their patients. Objectives: (1) develop an Minimum Viable Product (MVP) that increases PN operational efficiencies, facilitates seamless communications, collaboration, and knowledge transfer between PNs, patients, patients’ families, and caregivers; (2) obtain PN, patient, and clinician feedback, and (3) integrate MyNavigator with Electronic Health Records. Specific Aims: (1) establish feasibility as a tool for PNs, (2) build a human-centered design prototype, and (3) test effectiveness among 25+ users. Research Design & Methods rely on Project Management best practices, establishing a need using the York Method for literature reviews, Agile software development for solution development, and heuristic evaluation for usability. Formative and summative testing will be completed upon MVP development at MedStar Health facilities. Technological Innovation includes leveraging Avident’s existing intellectual property, which is protected by two patent applications, and creating a brand new tool to identify and serve the needs of PNs. Expected results: (1) MyNavigator refined utilizing stakeholder focus groups and validated with survey data and quantitative back-end app data. (2) MyNavigator improves communication and patient engagement while reducing cancer care team patient anxiety.

Avident Health 与 MedStar 健康研究所 (MHRI) 合作，将开发 MyNavigator mHealth 应用程序，并针对乳腺癌患者导航器 (PN) 及其患者进行可用性研究 目标：(1) 开发最小可行产品 (MVP)。提高 PN 运营效率，促进 PN、患者、患者家属和护理人员之间的无缝沟通、协作和知识转移 (2) 获取 PN、患者和临床医生的反馈；以及(3) 将 MyNavigator 与电子健康记录集成。具体目标：(1) 确立作为 PN 工具的可行性，(2) 构建以人为本的设计原型，以及 (3) 在 25 个以上用户中测试有效性。依靠项目管理最佳实践，使用约克方法确定文献综述的需求，解决方案开发的敏捷软件开发以及可用性的启发式评估将在 MedStar Health 设施的 MVP 开发后完成。创新包括利用 Avident 的现有知识产权（该知识产权受两项专利申请保护），以及创建一个全新的工具来识别和满足 PN 的需求。 预期结果：(1) MyNavigator 利用利益相关者焦点小组进行改进，并通过调查数据和定量进行验证。 (2) MyNavigator 改善沟通和患者参与度，同时减少癌症护理团队患者的焦虑。